Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
CEO
Miroslav Gasparek is a PhD candidate in Engineering Science at the University of Oxford, where he focuses on applications of control theory and machine learning in synthetic biology. He is also an affiliate of the Bio Policy and Practices Lab at Stanford University, where he works on biosecurity and biosafety challenges associated with synthetic biology. His biological security work also involves the development of the Slovak national biosecurity policy in collaboration with the WHO.
Miro holds a First Class M. Eng. degree in Biomedical Engineering from Imperial College London. During his time at Imperial, he performed research in systems and synthetic biology at the Reiko Tanaka lab at Imperial, the Richard Murray lab at the California Institute of Technology and the Drew Endy lab at Stanford University.
He is the Co-Founder and CEO of a pre-seed stealth startup developing a novel platform technology providing faster, cheaper, and more efficient manufacturing of the mRNA with improved properties. His venture is backed by Y Combinator, Civilization Ventures, and select value-added angels, as well as BARDA-affiliated health security accelerator.
Miro’s life science investing experiences include his position as a Venture Fellow at Civilization Ventures, an early-stage, Silicon Valley-based VC fund, as well as a Fellow at Nodes Advisors, a Swiss life science transaction advisory boutique. He is an alumnus of the Newton Venture Program, designed by the London Business School and LocalGlobe VC, and completed several VC-focused courses, including RA Capital Management’s the “Business of Biotech” and the Harvard Biotech Club’s “The Crossover”.
Miro has held several consulting and advisory roles. In addition to VC funds in Switzerland, the UK, and the US, he has advised the Slovak Ministry of Health on COVID-19 modelling, the Slovak Academy of Sciences on spinning out its cancer research, and two private networks of Slovak hospitals on research translation and innovation. He is passionate about promoting synthetic biology, bioengineering and entrepreneurship in Slovakia through op-eds and popularisation efforts.
When he is not immersed in research, biotech entrepreneurship and life science investing, Miro enjoys discussions about politics and economics, reading books, lifting weights, and playing the accordion.